azathioprine

azathioprine is a potent immunosuppressive medication belonging to the class of antimetabolites. It is primarily used to prevent organ rejection following kidney transplantation and to treat various autoimmune disorders. The drug functions as a prodrug for mercaptopurine, interfering with purine synthesis and thereby inhibiting the proliferation of lymphocytes. Its development at the Wellcome Research Laboratories in the 1950s marked a significant advancement in immunosuppression and organ transplantation.

Medical uses

Azathioprine is a cornerstone therapy for preventing rejection in solid organ transplant recipients, particularly after kidney transplantation, and is often used in conjunction with glucocorticoids and calcineurin inhibitors like tacrolimus. It is also widely employed in the management of several autoimmune conditions, including inflammatory bowel disease such as Crohn's disease and ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus, autoimmune hepatitis, and certain forms of vasculitis like granulomatosis with polyangiitis. Its use in dermatology extends to conditions like pemphigus vulgaris and severe atopic dermatitis. The decision to initiate therapy is often guided by organizations like the American College of Rheumatology and involves careful patient assessment due to its risk profile.

Adverse effects

The most serious adverse effect associated with azathioprine is myelosuppression, leading to leukopenia, thrombocytopenia, and anemia, which necessitates regular monitoring of blood counts. Significant hepatotoxicity and pancreatitis can also occur. A notable, albeit rare, complication is a severe idiosyncratic flu-like illness characterized by hypotension and nausea. There is an increased long-term risk of malignancy, particularly non-Hodgkin lymphoma and skin cancer, attributed to its immunosuppressive action. The enzyme thiopurine methyltransferase plays a crucial role in its metabolism, and genetic deficiency in TPMT can lead to profound and life-threatening toxicity, prompting testing recommended by agencies like the Food and Drug Administration.

Pharmacology

Azathioprine is a prodrug that is non-enzymatically cleaved in the body to its active metabolite, mercaptopurine. Mercaptopurine is then converted into active thioguanine nucleotides which are incorporated into DNA and RNA, ultimately inhibiting purine synthesis and cellular proliferation. This mechanism preferentially affects rapidly dividing cells, such as lymphocytes involved in the immune response. The metabolism of azathioprine involves several key enzymes, including thiopurine methyltransferase and xanthine oxidase; interactions with drugs like allopurinol, an xanthine oxidase inhibitor, require significant dose reductions to avoid toxicity. Its pharmacokinetics are variable, influenced by genetic factors and concomitant medications.

History

Azathioprine was first synthesized in 1957 by George H. Hitchings and Gertrude B. Elion at the Wellcome Research Laboratories in Tuckahoe, New York, as part of their pioneering work on purine analogues which later earned them the Nobel Prize in Physiology or Medicine in 1988. Its immunosuppressive properties were soon recognized, and it was introduced into clinical practice by surgeon Joseph E. Murray at Peter Bent Brigham Hospital in Boston, playing a pivotal role in the early success of kidney transplantation. The first successful kidney transplant using azathioprine was performed in 1962, a milestone that helped establish the field of transplant surgery. Its subsequent application expanded from transplantation to a wide array of autoimmune disorders throughout the latter half of the 20th century.

Society and culture

Azathioprine is available under various brand names globally, including Imuran and Azasan. It is on the World Health Organization's List of Essential Medicines, underscoring its importance in health systems. The drug has been the subject of numerous clinical trials coordinated by entities like the National Institutes of Health and the European League Against Rheumatism. Its cost and accessibility vary, with generic formulations widely available. The legacy of azathioprine is deeply intertwined with the history of organ transplantation, a narrative featured in institutions like the Smithsonian Institution and documented by the National Library of Medicine. Its development story is a classic example of translational research bridging basic biochemistry to clinical medicine.

Category:Drugs